Jump to Navigation
Home ›

Daytrana: A Long and Winding Road to Approval

On April 6, 2006, the FDA announced the approval of Daytrana, a transdermal patch version of Ritalin (methylphenidate). While you wouldn’t know it by the gushy promotional copy on Daytrana’s website (www.daytrana.com), the Ritalin patch just barely squeaked through the FDA approval process.

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.

Current Issue

Treatment of Depression

July / August, 2010
Vol: 8 Issue: 7
Read More
Previous Issues

Psychiatry in the News

To help members of the general public understand the sometimes complicated world of psychiatry, TCPR publisher and editor-in-chief Dr. Daniel Carlat has joined AOL Health as their mental health expert and blogger. You can read his AOL blog here.